246720.Kq
246720.KQ operates in the healthcare services and equipment industry, primarily engaged in the distribution of medical equipment and supplies.
Business. 246720.KQ operates in the healthcare services and equipment industry, primarily engaged in the distribution of medical equipment and supplies.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
246720.KQ operates in the healthcare services and equipment industry, primarily engaged in the distribution of medical equipment and supplies.
The company's capital structure is characterized by a debt-to-equity ratio of 0.3, indicating a relatively conservative leverage position. Despite holding significant cash and equivalents of KRW 2,906,053,460, the company reported negative operating and free cash flows of KRW -3,349,535,960 and KRW -2,775,604,040, respectively, suggesting liquidity constraints. The current ratio of 4.11 indicates strong short-term liquidity, with current assets significantly outpacing current liabilities.
Profitability metrics reveal a challenging financial position, with a return on equity of -0.3581 and a return on assets of -0.2133, both well below the industry median for medical equipment and supplies distribution. The company reported a net loss of KRW 3,303,456,540, with operating income also in negative territory at KRW -2,589,698,780, indicating significant operational inefficiencies.
The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic and regulatory risks. No material revenue concentration by geography is reported, but the absence of segmental or geographic breakdowns limits visibility into potential vulnerabilities.
The company's growth trajectory is uncertain, with no disclosed revenue growth or decline in the most recent financial period. The lack of historical revenue data prevents a meaningful assessment of growth trends. No forward-looking guidance is provided, and the absence of capital expenditure plans beyond KRW -29,623,500 suggests limited investment in future capacity.
Risk factors include the company's negative cash flows and operating losses, which could pressure liquidity if cash reserves are not replenished. The risk assessment indicates low dilution risk, with no immediate filing-based flags detected. However, the company's negative net income and operating cash flow could necessitate future financing, potentially leading to equity dilution.
Recent events include the latest financial filing, which disclosed the company's significant losses and negative cash flows. No recent earnings call transcripts or material regulatory filings are available to provide additional context on the company's strategic direction or operational challenges.
- The company is operating at a significant net loss, with negative operating and free cash flows.
- The capital structure is relatively conservative, with a low debt-to-equity ratio and strong current ratio.
- Profitability metrics are well below industry norms, indicating operational inefficiencies.
- The company lacks geographic and segmental diversification, increasing exposure to regional risks.
- No immediate liquidity or dilution risks are flagged, but the financial position remains precarious.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- No immediate filing-based liquidity or dilution flags were detected.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- 246720.KQ Market data — financials · 2026-05-26